Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random
ARCA

Sarepta Therapeutics Inc (NASDAQ:SRPT) Gets Off To A Running Start With Eteplirsen

- January 11, 2017
sage

SAGE Therapeutics Inc (NASDAQ:SAGE): What Just Happened, And What’s Next?

Novartis AG (NYSE:NVS) And Pfizer Inc. (NYSE:PFE) Are In A Race To Gain Favor In Breast Cancer

Teva Pharmaceutical Industries Ltd

A U.S Court Will Hear Nothing Of Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) Claims Of Patent Infringement

novo nordisk nvo

Weekly Biotech Report Covering Novo Nordisk A/S (NYSE:NVO)

merck-co-inc

Merck & Co., Inc. (NYSE:MRK) To Drop Hepatitis C Therapies Development

- October 2, 2017 0

GlaxoSmithKline plc (ADR)(NYSE:GSK) Axes More Than 30 Drug-Research Projects

Andy Parker - July 28, 2017 0

Merck & Co., Inc. (NYSE:MRK) Keytruda Reaches Blockbuster Status As European...

- October 30, 2017 0
juno

As Good News Flows Out, Smart Money Flows into Juno Therapeutics

ME Staff - June 26, 2015 0

Here’s What Just Happened With Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and Aeterna...

- July 21, 2017 0
FDA

All You Need To Know About Array Biopharma Inc’s (NASDAQ:ARRY) Upcoming...

ME Staff - June 8, 2016 0

CVS Health Corp (NYSE:CVS) Study Reveals 66% of Americans Believe That...

- August 21, 2017 0
biotech

Biotech Movers: Insys Therapeutics Inc (NASDAQ:INSY) and Cempra Inc (NASDAQ:CEMP)

Jennifer Aldershot - July 5, 2016 0

India’s Government Rejects Appeal By Boston Scientific Corporation (NYSE:BSX) To Increase...

- May 10, 2017 0

Novartis AG (NYSE:NVS) Announces Positive Phase III Results For MS Drug

- August 26, 2016 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

August 2, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 13, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 6, 2026

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019